These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7044823)

  • 1. A calcium-dependent protease selectively degrading the 160 000 Mr component of neurofilaments is associated with the cytoskeletal preparation of the spinal cord and has an endogenous inhibitory factor.
    Tashiro T; Ishizaki Y
    FEBS Lett; 1982 May; 141(1):41-4. PubMed ID: 7044823
    [No Abstract]   [Full Text] [Related]  

  • 2. A high molecular weight inhibitor of Ca2+ -dependent neutral protease in rat brain.
    Nishiura I; Tanaka K; Murachi T
    Experientia; 1979 Aug; 35(8):1006-7. PubMed ID: 477856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide hydrolases in spinal cord and brain of the rabbit.
    Serra S; Grynbaum A; Lajtha A; Marks N
    Brain Res; 1972 Sep; 44(2):579-92. PubMed ID: 5075708
    [No Abstract]   [Full Text] [Related]  

  • 4. A calcium-activated protease which preferentially degrades the 160-kDa component of the neurofilament triplet.
    Ishizaki Y; Tashiro T; Kurokawa M
    Eur J Biochem; 1983 Mar; 131(1):41-5. PubMed ID: 6299732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of leupeptin, molybdate and calcium ions on estrogen receptor stability.
    Ratajczak T; Luc T; Samec AM; Hähnel R
    FEBS Lett; 1981 Dec; 136(1):115-8. PubMed ID: 7032972
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium-dependent degradation of mammalian neurofilaments by soluble tissue factor(s) from rat spinal cord.
    Schlaepfer WW; Freeman LA
    Neuroscience; 1980; 5(12):2305-14. PubMed ID: 7193294
    [No Abstract]   [Full Text] [Related]  

  • 7. A calcium-dependent protease associated with the neural cytoskeleton. Purification and partial characterisation.
    Ishizaki Y; Kurokawa M; Takahashi K
    Eur J Biochem; 1985 Jan; 146(2):331-7. PubMed ID: 2981687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A calcium-activated neutral protease in the frog nervous system which degrades rapidly transported axonal proteins.
    Zalewska T; Kanje M; Edström A
    Brain Res; 1986 Aug; 381(1):58-62. PubMed ID: 2428432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease inhibitors produced by microorganisms.
    Umezawa H
    Acta Biol Med Ger; 1977; 36(11-12):1899-915. PubMed ID: 358710
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzymatic degradation of the encephalitogenic protein.
    Einstein ER; Csejtey J; Davis WJ; Lajtha A; Marks N
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:363-75. PubMed ID: 5373034
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies of a calcium-activated neutral protease from chicken skeletal muscle. I. Purification and characterization.
    Ishiura S; Murofushi H; Suzuki K; Imahori K
    J Biochem; 1978 Jul; 84(1):225-30. PubMed ID: 29038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a brain calcium-activated protease that degrades neurofilament proteins.
    Zimmerman UJ; Schlaepfer WW
    Biochemistry; 1982 Aug; 21(17):3977-82. PubMed ID: 6751383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine cardiac calcium-dependent proteases: Resolution of two forms with different requirements for calcium.
    Mellgren RL
    FEBS Lett; 1980 Jan; 109(1):129-33. PubMed ID: 6766404
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms underlying the neuronal response to ischemic injury. Calcium-activated proteolysis of neurofilaments.
    Schlaepfer WW; Zimmerman UJ
    Prog Brain Res; 1985; 63():185-96. PubMed ID: 3915124
    [No Abstract]   [Full Text] [Related]  

  • 15. Protein turnover in myelin and mitochondrial fractions.
    Marks N; Lajtha A
    Vopr Biokhim Mozga; 1972; 7(0):43-54. PubMed ID: 4679757
    [No Abstract]   [Full Text] [Related]  

  • 16. Ca-activated neutral protease and its inhibitors: in vitro effect on intact myofibrils.
    Sugita H; Ishiura S; Suzuki K; Imahori K
    Muscle Nerve; 1980; 3(4):335-9. PubMed ID: 6251364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies for the inhibition of neuropeptide-metabolizing enzymes.
    Turner AJ
    Biochem Soc Trans; 1986 Apr; 14(2):399-401. PubMed ID: 3011551
    [No Abstract]   [Full Text] [Related]  

  • 18. Peripheral nerve autografts increase soleus muscle hydrolase activity.
    Boegman RJ; Scarth B
    Can J Physiol Pharmacol; 1982 Jan; 60(1):41-6. PubMed ID: 7039788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of enzymatic degradation in the inactivation of tachykinin neurotransmitters in neonatal rat spinal cord.
    Suzuki H; Yoshioka K; Yanagisawa M; Urayama O; Kurihara T; Hosoki R; Saito K; Otsuka M
    Br J Pharmacol; 1994 Sep; 113(1):310-6. PubMed ID: 7529113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the protein kinase activity associated with rat neurofilament preparations.
    Julien JP; Smoluk GD; Mushynski WE
    Biochim Biophys Acta; 1983 Jan; 755(1):25-31. PubMed ID: 6681714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.